Susquehanna International Group’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
MCO
LG
CFM
Susquehanna International Group's CLPT Position: Q2 2026 in Review
Susquehanna International Group increased its ClearPoint Neuro (CLPT) stake by 76% in Q2 2026, buying an estimated $1.3M and bringing the position to 240,282 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4929.
Susquehanna International Group first reported a position in CLPT in Q1 2021 and has held it in 19 quarters since. The position peaked at $7.83M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- Susquehanna International Group held 240,282 shares of ClearPoint Neuro worth $4.29M as of Q2 2026.
- Susquehanna International Group bought 103,998 ClearPoint Neuro shares in Q2 2026, an estimated $1.3M.
- ClearPoint Neuro made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #4929 holding.
- Susquehanna International Group first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 19 quarters since.
- Susquehanna International Group's ClearPoint Neuro position peaked at $7.83M in Q4 2024.
- 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.